Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ABHD2 activity is not required for the non-genomic action of progesterone on human sperm.

Human reproduction (Oxford, England)·2026
Same author

Self-Organized Men's Mental Health and Well-Being Groups-An Emerging Social Development.

American journal of men's health·2026
Same author

High-throughput phenotypic screening of Medicines for Malaria Venture's Hit Generation Library 1 identifies new nematocidal chemotypes.

International journal for parasitology. Drugs and drug resistance·2026
Same author

Visceral leishmaniasis elimination in South Asia: lessons learnt can inform disease elimination in East Africa.

BMJ global health·2026
Same author

A prospective cohort study to describe the morphology of buboes in patients with bubonic plague using ultrasound imaging.

PLoS neglected tropical diseases·2026
Same author

Evidence on the preparedness and practice needs of the home care workforce to support older LGBTQ+ people: a rapid review protocol.

BMJ open·2026

Related Experiment Video

Updated: May 8, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Open source drug discovery - a limited tutorial.

Murray N Robertson1, Paul M Ylioja1, Alice E Williamson1

  • 1School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia.

Parasitology
|August 30, 2013
PubMed
Summary
This summary is machine-generated.

Open science facilitates experimental research, like drug discovery, by sharing data and ideas. Implementing straightforward steps and utilizing online tools can overcome challenges and psychological barriers to open research practices.

Related Experiment Videos

Last Updated: May 8, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Area of Science:

  • Experimental laboratory-based research
  • Drug discovery research

Background:

  • Open science is an emerging paradigm for experimental research.
  • Drug discovery projects can benefit from open science principles.

Purpose of the Study:

  • To describe practical steps for implementing open science in experimental research.
  • To highlight challenges and solutions for adopting open research practices.

Main Methods:

  • Leveraging existing and inexpensive online tools for data sharing.
  • Documenting straightforward implementation steps for research programs.

Main Results:

  • Online tools effectively address many technical challenges of open science.
  • Psychological barriers to data and idea sharing remain significant.

Conclusions:

  • Adopting open science requires addressing both technical and psychological aspects.
  • Practical strategies can facilitate the transition towards more open research programs.